Twitter Beğeni Hilesi

VIDEO: LDI Fellow Lauren Eberly (Lauren A. Eberly, MD, MPH) discusses her study which found that a simple intervention increased the uptake of guideline-directed heart failure therapy drugs by 53% at a Navajo Nation hospital in New Mexico. Watch here: ldi.upenn.edu/our-work/resea…

📢Simultaneous Publication at #SCAI2024! 💡In this multicenter, first-in-human study, use of the Hēlo #PE Thrombectomy Catheter was feasible & safe for the treatment of acute PE. Tai Kobayashi Read more now: ➡️doi.org/10.1016/j.jsca… Ido Weinberg, MD

💥Featured #LateBreaker Clinical Research at #SCAI2024: 💡First in Human Safety & Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of #PulmonaryEmbolism (The ENGULF Trial) Read the abstract & article: doi.org/10.1016/j.jsca… Tai Kobayashi

Tai Kobayashi presents & publishes ENGULF trial: first in human experience with novel E2 Helo Catheter at SCAI Now 2024. 15F catheter w/ 24F expandable tip, dual articulations for navigation, & an internal agitator. Good safety and RV improvement. jscai.org/article/S2772-…

SCAI Now Ramesh Daggubati Leah Raj Robert Riley Khaldoon Alaswad MD Hany Ragy Mamas A. Mamas Srihari S. Naidu, MD George Dangas, MD, MACC, MSCAI Dr Roxana Mehran Saraschandra Vallabhajosyula, MD MSc Poonam Velagapudi Sunil V. Rao Babar Basir Alex Truesdell Triston B.B.J. Smith MD MGM FSCAI Melvin R. Echols, MD, FACC, FHFSA, FASPC Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 MedStar Washington UH Harrington Heart & Vascular Institute University Hospitals Aditya Bharadwaj Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI Chadi Alraies, MD FACC FSCAI Yiannis Chatzizisis CindyGrines, MD Hayder Hashim Adhir Shroff Behind the scene :) Chadi Alraies, MD FACC FSCAI Watch SCAI Now TV #SCAI2024 interviews and more coming !! youtube.com/@SCAITV/playli…

Late Breaker Dr. Tai Kobayashi speaks with Dr. Alraies at SCAI Scientifi... youtu.be/H33qRl7Lr-8?si… via YouTube Thanks to my co-investigators and my mentors Jay Giri and Eric Secemsky MD MSc. Congratulations to endovascular engineering for a successful First in Human study!

Matt Belford SCAI Now Santul Bapat Wake Forest Baptist Health Cardiology Wake Forest Internal Medicine Residency Taylor Nipp AngioDynamics, Inc. #ŌNŌ_helps #ŌNŌ_for_endocarditis Jay Giri Tai Kobayashi

ENGULF Safety and Feasibility Study presented at #SCAI2024. YCRG #ACL analysis. Read the simultaneous publication in MyJSCAI: jscai.org/article/S2772-…

Thrilled to hear from Penn Cardiology's very own Tai Kobayashi🩺 during the last Penn Presbyterian #GrandRounds of the year this morning for an engaging presentation on #renaldenervation 🙌 #MedEd #Cardiology

A new #LateBreaking summary from #SCAI2024 evaluates the safety and feasibility of using a new dual mechanism moderate bore Hēlo #PulmonaryEmbolism thrombectomy system. ➡️Read late-breaking science: ow.ly/3QvQ50RHhnl #InterventionalCardiology #CardioTwitter #PE MyJSCAI

🎥 Discover key insights from Tai Kobayashi’s #LateBreaking presentation at #SCAI2024: First in Human Safety and Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (The ENGULF Trial). Watch now ➡️ youtu.be/H33qRl7Lr-8?si… Chadi Alraies, MD FACC FSCAI

🚨 Is non-fasting before coronary intervention safe? Check out the results of the TONIC trial in this new issue of #JACCINT: bit.ly/3KmLAqg

I’m walking around MSG in NYC and somebody stops me and asks: “are there good places to eat around here”. I literally just stared at him in confusion…

Introducing the MICHIGAN procedure; another tool in the box for transcatheter mass extraction. This was the 17th case of ONO in world, first through subclavian access and first use as a “global” full body embolic protection. Dr. Gilbert Tang rb.gy/2sd1tp

A little late but congrats to VA Philadelphia for being first to do a rRDN nationally! So proud of our group and our institution for the vision and the new therapies we can offer our veterans! Jay Giri Debbie Cohen MD 🇮🇱 🇺🇸🇿🇦 facebook.com/share/p/pHZeHK…

Landmark PERSEVERE trial announced European Society of Cardiology 2024 RCT for high risk massive PE: large bore thrombectomy vs standard of care. Mortality 20-30% with standard of care 1 past RCT in this group with only 8 patients. The “Golden Era of PE RCT” continues! sciencedirect.com/science/articl…